These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 31801542)
41. Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys. Dunne EM; Satzke C; Ratu FT; Neal EFG; Boelsen LK; Matanitobua S; Pell CL; Nation ML; Ortika BD; Reyburn R; Jenkins K; Nguyen C; Gould K; Hinds J; Tikoduadua L; Kado J; Rafai E; Kama M; Mulholland EK; Russell FM Lancet Glob Health; 2018 Dec; 6(12):e1375-e1385. PubMed ID: 30420033 [TBL] [Abstract][Full Text] [Related]
42. Colonization with 19F and other pneumococcal conjugate vaccine serotypes in children in St. Louis, Missouri, USA. McFarland M; Szasz TP; Zhou JY; Motley K; Sivapalan JS; Isaacson-Schmid M; Todd EM; Hogan PG; Fritz SA; Burnham CD; Hoffmann S; Morley SC Vaccine; 2017 Aug; 35(34):4389-4395. PubMed ID: 28687405 [TBL] [Abstract][Full Text] [Related]
43. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden. Galanis I; Lindstrand A; Darenberg J; Browall S; Nannapaneni P; Sjöström K; Morfeldt E; Naucler P; Blennow M; Örtqvist Å; Henriques-Normark B Eur Respir J; 2016 Apr; 47(4):1208-18. PubMed ID: 26797033 [TBL] [Abstract][Full Text] [Related]
44. PCV13-vaccinated children still carrying PCV13 additional serotypes show similar carriage density to a control group of PCV7-vaccinated children. Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gruber WC; Scott DA Vaccine; 2017 Feb; 35(6):945-950. PubMed ID: 28087146 [TBL] [Abstract][Full Text] [Related]
45. Cross-sectional health centre and community-based evaluation of the impact of pneumococcal and malaria vaccination on antibiotic prescription and usage, febrile illness and antimicrobial resistance in young children in Malawi: the IVAR study protocol. Singleton D; Ibarz-Pavon A; Swarthout TD; Bonomali F; Cornick J; Kalizang'oma A; Ntiza N; Brown C; Chipatala R; Nyangulu W; Chirombo J; Kawalazira G; Chibowa H; Mwansambo C; Maleta KM; French N; Heyderman RS BMJ Open; 2023 May; 13(5):e069560. PubMed ID: 37173105 [TBL] [Abstract][Full Text] [Related]
46. The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study. van Deursen AMM; van Houten MA; Webber C; Patton M; Scott D; Patterson S; Jiang Q; Gruber WC; Schmoele-Thoma B; Grobbee DE; Bonten MJM; Sanders EAM Clin Infect Dis; 2018 Jun; 67(1):42-49. PubMed ID: 29324986 [TBL] [Abstract][Full Text] [Related]
47. Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece. Grivea IN; Priftis KN; Giotas A; Kotzia D; Tsantouli AG; Douros K; Michoula AN; Syrogiannopoulos GA Vaccine; 2014 Nov; 32(48):6513-20. PubMed ID: 25252194 [TBL] [Abstract][Full Text] [Related]
48. Expansion of pneumococcal serotype 23F and 14 lineages with genotypic changes in capsule polysaccharide locus and virulence gene profiles post introduction of pneumococcal conjugate vaccine in Blantyre, Malawi. Cave R; Kalizang'oma A; Chaguza C; Mwalukomo TS; Kamng'ona A; Brown C; Msefula J; Bonomali F; Nyirenda R; Swarthout TD; Kwambana-Adams B; French N; Heyderman RS Microb Genom; 2024 Jun; 10(6):. PubMed ID: 38896467 [TBL] [Abstract][Full Text] [Related]
49. Carriage of Haemophilus influenzae is associated with pneumococcal vaccination in Italian children. Camilli R; Vescio MF; Giufrè M; Daprai L; Garlaschi ML; Cerquetti M; Pantosti A Vaccine; 2015 Aug; 33(36):4559-64. PubMed ID: 26190092 [TBL] [Abstract][Full Text] [Related]
50. Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi. Thindwa D; Mwalukomo TS; Msefula J; Jambo KC; Brown C; Kamng'ona A; Mwansambo C; Ojal J; Flasche S; French N; Heyderman RS; Swarthout TD AIDS; 2022 Nov; 36(14):2045-2055. PubMed ID: 35983828 [TBL] [Abstract][Full Text] [Related]
51. Effectiveness of 7- and 13-Valent Pneumococcal Conjugate Vaccines in a Schedule Without a Booster Dose: A 10-Year Observational Study. Jayasinghe S; Chiu C; Quinn H; Menzies R; Gilmour R; McIntyre P Clin Infect Dis; 2018 Jul; 67(3):367-374. PubMed ID: 29471432 [TBL] [Abstract][Full Text] [Related]
52. Herd immunity alters the conditions for performing dose schedule comparisons: an individual-based model of pneumococcal carriage. Yang A; Cai F; Lipsitch M BMC Infect Dis; 2019 Mar; 19(1):227. PubMed ID: 30836941 [TBL] [Abstract][Full Text] [Related]
53. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290 [TBL] [Abstract][Full Text] [Related]
54. Epidemiological and molecular characterization of Streptococcus pneumoniae carriage strains in pre-school children in Arkhangelsk, northern European Russia, prior to the introduction of conjugate pneumococcal vaccines. Vorobieva S Jensen V; Furberg AS; Slotved HC; Bazhukova T; Haldorsen B; Caugant DA; Sundsfjord A; Valentiner-Branth P; Simonsen GS BMC Infect Dis; 2020 Apr; 20(1):279. PubMed ID: 32293324 [TBL] [Abstract][Full Text] [Related]
55. Impact of the Hajj on pneumococcal carriage and the effect of various pneumococcal vaccines. Edouard S; Al-Tawfiq JA; Memish ZA; Yezli S; Gautret P Vaccine; 2018 Nov; 36(48):7415-7422. PubMed ID: 30236632 [TBL] [Abstract][Full Text] [Related]
56. Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination. Orsi A; Ansaldi F; Trucchi C; Rosselli R; Icardi G Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428964 [TBL] [Abstract][Full Text] [Related]
57. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Davis SM; Deloria-Knoll M; Kassa HT; O'Brien KL Vaccine; 2013 Dec; 32(1):133-45. PubMed ID: 23684824 [TBL] [Abstract][Full Text] [Related]
58. Understanding the Evolution of Antibiotic-nonsusceptible Pneumococcal Nasopharyngeal Colonization Following Pneumococcal Conjugate Vaccine Implementation in Young Children. Danino D; Givon-Lavi N; Ben-Shimol S; Greenberg D; Dagan R Clin Infect Dis; 2019 Aug; 69(4):648-656. PubMed ID: 30371763 [TBL] [Abstract][Full Text] [Related]
59. Decreased Carriage and Genetic Shifts in the Streptococcus pneumoniae Population After Changing the Seven-valent to the Thirteen-valent Pneumococcal Vaccine in Norway. Steens A; Caugant DA; Aaberge IS; Vestrheim DF Pediatr Infect Dis J; 2015 Aug; 34(8):875-83. PubMed ID: 26020410 [TBL] [Abstract][Full Text] [Related]
60. Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR). Abu Seir R; Azmi K; Hamdan A; Namouz H; Jaar F; Jaber H; Rubin C; Doron D; Rahav G; Abdeen Z; Regev-Yochay G PLoS One; 2018; 13(11):e0206927. PubMed ID: 30418989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]